false 0001823857 0001823857 2023-12-27 2023-12-27 0001823857 VHAQ:UnitsMember 2023-12-27 2023-12-27 0001823857 us-gaap:CommonStockMember 2023-12-27 2023-12-27 0001823857 VHAQ:WarrantsMember 2023-12-27 2023-12-27 0001823857 us-gaap:RightsMember 2023-12-27 2023-12-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 27, 2023

 

Viveon Health Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-39827   85-2788202
(State or other jurisdiction
of  incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

3480 Peachtree Road NE
2nd FloorSuite #112
Atlanta
, Georgia 30326

(Address of Principal Executive Offices and Zip Code)

 

Registrant’s telephone number, including area code: (404) 861-5393

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         
Units   VHAQU   NYSE American, LLC
         
Common Stock   VHAQ   NYSE American, LLC
         
Warrants   VHAQW   *
         
Rights   VHAQR   NYSE American, LLC

 

* The Warrants trade on the OTC Pink Marketplace maintained by the OTC Markets Group, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

Viveon Health Acquisition Corp., a Delaware corporation (the “Company”) held its 2023 Annual Meeting of Stockholders (“Annual Meeting”) at 10:30 a.m. Eastern Time on December 27, 2023 for the purpose of approving: (i) the Director Election Proposal; (ii) the Auditor Ratification Proposal; and (iii) the Adjournment Proposal, if needed. For more information on these proposals, which are described below, please refer to the Company’s proxy statement dated November 30, 2023. As of the record date of November 13, 2023, there was a total of 6,648,665 shares of common stock issued and outstanding and entitled to vote at the Annual Meeting. Proxies were received for 5,939,581 shares of common stock, or approximately 89.33% of the shares issued and outstanding and entitled to vote at the Annual Meeting; therefore a quorum was present.

 

Director Election Proposal — a proposal to re-elect five current directors to the Company’s Board of Directors.

 

The five director nominees proposed by the Company’s Board of Directors were each elected to serve as a director until their successors are duly elected and qualified or until their earlier resignation or removal. The final voting results for each nominee were as follows:

 

Nominee  For  Withheld   Broker Non-Vote  
            
Jagi Gill   5,097,852   1   841,728  
Rom Papadopoulos   5,097,852   1   841,728  
Demetrios (Jim) G. Logothetis   5,097,852   1   841,728  
Brian Cole   5,097,602   251   841,728  
Doug Craft   5,097,852   1   841,728  

 

Auditor Ratification Proposal — a proposal to ratify the appointment of Marcum LLP, as the Company’s independent auditors, for the fiscal year ending December 31, 2022.

 

Shareholders voted to ratify the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending December 31, 2022. The proposal received the following final voting results:

 

For  Against  Abstain   Broker Non-Vote  
5,939,330   250   1   0  

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit   Description
104   Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIVEON HEALTH ACQUISITION CORP.
     
Date: December 29, 2023 By: /s/ Jagi Gill
  Name: Jagi Gill
  Title:

Chief Executive Officer

 

 

 

v3.23.4
Cover
Dec. 27, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 27, 2023
Entity File Number 001-39827
Entity Registrant Name Viveon Health Acquisition Corp.
Entity Central Index Key 0001823857
Entity Tax Identification Number 85-2788202
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3480 Peachtree Road NE
Entity Address, Address Line Two 2nd Floor
Entity Address, Address Line Three Suite #112
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30326
City Area Code (404)
Local Phone Number 861-5393
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units  
Title of 12(b) Security Units
Trading Symbol VHAQU
Security Exchange Name NYSEAMER
Common Stock [Member]  
Title of 12(b) Security Common Stock
Trading Symbol VHAQ
Security Exchange Name NYSEAMER
Warrants  
Title of 12(b) Security Warrants
Trading Symbol VHAQW
Rights [Member]  
Title of 12(b) Security Rights
Trading Symbol VHAQR
Security Exchange Name NYSEAMER

Grafico Azioni Viveon Health Acquisition (AMEX:VHAQ)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Viveon Health Acquisition
Grafico Azioni Viveon Health Acquisition (AMEX:VHAQ)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Viveon Health Acquisition